clinical trials glp 1 Could GLP-1 medications help slow cancer progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to GLP-1 receptor agonists and cardiovascular

Light Bruising: Occasional light bruising may occur as part of the healing process

Cell Cycle 10 (24), 42304236

A study of the subcellular localization of GPx1 variants to appreciate the molecular consequences associated with diseases demonstrated that the primary sequence of GPx1 affects subcellular localization and that the sequence and cell location can be important to understand the impact of GPx1 on human diseases, including cancer [24]

10.1046/j.1365-313x.1998.00319.x 133 SamsatlyJ.CopleyT

Author: Jay Fenster, Senior Manager, Content Marketing @ OUTFRONT Links to third-party content are not endorsed by OUTFRONT Media

Primary structure and functional characterization of a high-affinity glutamate transporter